↓ Skip to main content

Aripiprazole alone or in combination for acute mania

Overview of attention for article published in Cochrane database of systematic reviews, December 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
7 X users
facebook
1 Facebook page
wikipedia
6 Wikipedia pages

Citations

dimensions_citation
43 Dimensions

Readers on

mendeley
367 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Aripiprazole alone or in combination for acute mania
Published in
Cochrane database of systematic reviews, December 2013
DOI 10.1002/14651858.cd005000.pub2
Pubmed ID
Authors

Rachel Brown, Matthew J Taylor, John Geddes

Abstract

Bipolar disorder is a mental disorder characterised by episodes of elevated or irritable mood (manic or hypomanic episodes) and episodes of low mood and loss of energy (depressive episodes). Drug treatment is the first-line treatment for acute mania with the initial aim of rapid control of agitation, aggression and dangerous behaviour. Aripiprazole, an atypical antipsychotic, is used in the treatment of mania both as monotherapy and combined with other medicines. The British Association of Psychopharmacology guidelines report that, in monotherapy placebo-controlled trials, the atypical antipsychotics, including aripiprazole, have been shown to be effective for acute manic or mixed episodes.

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 367 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Colombia 1 <1%
Netherlands 1 <1%
South Africa 1 <1%
Unknown 363 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 55 15%
Researcher 45 12%
Student > Bachelor 36 10%
Student > Ph. D. Student 31 8%
Student > Doctoral Student 25 7%
Other 73 20%
Unknown 102 28%
Readers by discipline Count As %
Medicine and Dentistry 123 34%
Psychology 43 12%
Nursing and Health Professions 29 8%
Social Sciences 11 3%
Neuroscience 10 3%
Other 32 9%
Unknown 119 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 May 2023.
All research outputs
#5,189,022
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#7,107
of 11,499 outputs
Outputs of similar age
#54,625
of 308,102 outputs
Outputs of similar age from Cochrane database of systematic reviews
#143
of 211 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 308,102 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 211 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.